Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1998 1
2001 1
2002 24
2003 12
2004 22
2005 34
2006 19
2007 26
2008 27
2009 28
2010 23
2011 26
2012 37
2013 39
2014 40
2015 42
2016 55
2017 76
2018 57
2019 68
2020 60
2021 66
2022 73
2023 86
2024 29

Text availability

Article attribute

Article type

Publication date

Search Results

878 results

Results by year

Filters applied: . Clear all
Page 1
Pembrolizumab Versus Placebo as Second-Line Therapy in Patients From Asia With Advanced Hepatocellular Carcinoma: A Randomized, Double-Blind, Phase III Trial.
Qin S, Chen Z, Fang W, Ren Z, Xu R, Ryoo BY, Meng Z, Bai Y, Chen X, Liu X, Xiao J, Ho GF, Mao Y, Wang X, Ying J, Li J, Zhong W, Zhou Y, Siegel AB, Hao C. Qin S, et al. Among authors: chen x. J Clin Oncol. 2023 Mar 1;41(7):1434-1443. doi: 10.1200/JCO.22.00620. Epub 2022 Dec 1. J Clin Oncol. 2023. PMID: 36455168 Free PMC article. Clinical Trial.
Primary tumor associated macrophages activate programs of invasion and dormancy in disseminating tumor cells.
Borriello L, Coste A, Traub B, Sharma VP, Karagiannis GS, Lin Y, Wang Y, Ye X, Duran CL, Chen X, Friedman M, Sosa MS, Sun D, Dalla E, Singh DK, Oktay MH, Aguirre-Ghiso JA, Condeelis JS, Entenberg D. Borriello L, et al. Among authors: chen x. Nat Commun. 2022 Feb 2;13(1):626. doi: 10.1038/s41467-022-28076-3. Nat Commun. 2022. PMID: 35110548 Free PMC article.
Organophosphine-Catalyzed [4C+X] Annulations.
Li Y, Chen X, Chen X, Shen X. Li Y, et al. Among authors: chen x. Molecules. 2018 Nov 19;23(11):3022. doi: 10.3390/molecules23113022. Molecules. 2018. PMID: 30463230 Free PMC article. Review.
The effect of dietary carbohydrate and calorie restriction on weight and metabolic health in overweight/obese individuals: a multi-center randomized controlled trial.
Sun J, Ruan Y, Xu N, Wu P, Lin N, Yuan K, An S, Kang P, Li S, Huang Q, Yingzhang, Li Y, Su J, Ma W, Chen B, Zhang X, Chen X, Liang Y, Lu Z, Deng G, Zhang Z, Wang Y, Wen W, Zhang H, Chen H. Sun J, et al. Among authors: chen x. BMC Med. 2023 May 24;21(1):192. doi: 10.1186/s12916-023-02869-9. BMC Med. 2023. PMID: 37226271 Free PMC article. Clinical Trial.
Apatinib as second-line or later therapy in patients with advanced hepatocellular carcinoma (AHELP): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial.
Qin S, Li Q, Gu S, Chen X, Lin L, Wang Z, Xu A, Chen X, Zhou C, Ren Z, Yang L, Xu L, Bai Y, Chen L, Li J, Pan H, Cao B, Fang W, Wu W, Wang G, Cheng Y, Yu Z, Zhu X, Jiang D, Lu Y, Wang H, Xu J, Bai L, Liu Y, Lin H, Wu C, Zhang Y, Yan P, Jin C, Zou J. Qin S, et al. Among authors: chen x. Lancet Gastroenterol Hepatol. 2021 Jul;6(7):559-568. doi: 10.1016/S2468-1253(21)00109-6. Epub 2021 May 8. Lancet Gastroenterol Hepatol. 2021. PMID: 33971141 Clinical Trial.
Camrelizumab in Combination with Apatinib in Patients with Advanced Hepatocellular Carcinoma (RESCUE): A Nonrandomized, Open-label, Phase II Trial.
Xu J, Shen J, Gu S, Zhang Y, Wu L, Wu J, Shao G, Zhang Y, Xu L, Yin T, Liu J, Ren Z, Xiong J, Mao X, Zhang L, Yang J, Li L, Chen X, Wang Z, Gu K, Chen X, Pan Z, Ma K, Zhou X, Yu Z, Li E, Yin G, Zhang X, Wang S, Wang Q. Xu J, et al. Among authors: chen x. Clin Cancer Res. 2021 Feb 15;27(4):1003-1011. doi: 10.1158/1078-0432.CCR-20-2571. Epub 2020 Oct 21. Clin Cancer Res. 2021. PMID: 33087333 Clinical Trial.
A high throughput bispecific antibody discovery pipeline.
Segaliny AI, Jayaraman J, Chen X, Chong J, Luxon R, Fung A, Fu Q, Jiang X, Rivera R, Ma X, Ren C, Zimak J, Hedde PN, Shang Y, Wu G, Zhao W. Segaliny AI, et al. Among authors: chen x. Commun Biol. 2023 Apr 7;6(1):380. doi: 10.1038/s42003-023-04746-w. Commun Biol. 2023. PMID: 37029216 Free PMC article.
Arterial chemotherapy for hepatocellular carcinoma in China: consensus recommendations.
Zhao M, Guo Z, Zou YH, Li X, Yan ZP, Chen MS, Fan WJ, Li HL, Yang JJ, Chen XM, Xu LF, Zhang YW, Zhu KS, Sun JH, Li JP, Jin Y, Yu HP, Duan F, Xiong B, Yin GW, Lin HL, Ma YL, Wang HM, Gu SZ, Si TG, Wang XD, Zhao C, Yu WC, Guo JH, Zhai J, Huang YH, Wang WY, Lin HF, Gu YK, Chen JZ, Wang JP, Zhang YM, Yi JZ, Lyu N. Zhao M, et al. Hepatol Int. 2024 Feb;18(1):4-31. doi: 10.1007/s12072-023-10599-6. Epub 2023 Oct 21. Hepatol Int. 2024. PMID: 37864725
Asymmetric Total Synthesis of (+)-Alstonlarsine A.
Yao JJ, Ding R, Chen X, Zhai H. Yao JJ, et al. Among authors: chen x. J Am Chem Soc. 2022 Aug 10;144(31):14396-14402. doi: 10.1021/jacs.2c06518. Epub 2022 Jul 27. J Am Chem Soc. 2022. PMID: 35894835
878 results